HDAC9 and breast carcinoma: Here we show that TAZ may represent the principal mediator of these events and since TAZ and not YAP has been shown to confer cancer stem cell phenotype in breast cancer [33], the latter transcription factor may be dispensable for mediating the pro-EMT effects of HDAC inhibition.